Rappold Brian A
Mass Spectrometry Laboratory Corporation of America, 1904 TW Alexander Drive, Durham, NC 27703, USA.
Clin Lab Med. 2018 Sep;38(3):539-551. doi: 10.1016/j.cll.2018.05.003. Epub 2018 Jul 20.
Method development for diagnostic liquid-chromatography-tandem mass spectrometry (LC-MS/MS) assays are not broadly discussed in publications. Certain aspects of the development process are thus learned via experience. This article touches on a number of aspects that should be contemplated during method development for LC-MS/MS tests beyond sample preparation, chromatographic separation, and mass spectrometric detection. Utilization of factors intrinsic to LC-MS/MS, such as isotopically labeled internal standards and appraisal of transition ratios, engenders confidence in assay development and accelerates movement toward validation and testing.
诊断性液相色谱 - 串联质谱(LC-MS/MS)分析方法的开发在出版物中并未得到广泛讨论。因此,开发过程的某些方面是通过经验习得的。本文涉及了在LC-MS/MS检测方法开发过程中除样品制备、色谱分离和质谱检测之外应考虑的多个方面。利用LC-MS/MS固有的因素,如同位素标记内标和转换比评估,可增强分析方法开发的可信度,并加速迈向验证和测试的进程。